Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
10/2014
10/14/2014US8859725 Healthy kidney biomarkers
10/14/2014US8859723 Peptidomimetic macrocycles
10/14/2014US8859500 Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC
10/14/2014US8859492 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
10/14/2014US8859294 Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate
10/14/2014US8859284 Delivery of nanoparticles to neurons
10/14/2014US8858952 Methods and materials for generating T cells
10/09/2014WO2014165449A1 NOVEL α4β7 PEPTIDE ANTAGONISTS
10/09/2014WO2014165448A1 NOVEL α4β7 PEPTIDE DIMER ANTAGONISTS
10/09/2014WO2014165137A1 Compounds and methods for treating obesity and controlling weight
10/09/2014WO2014163344A1 Peptide for diagnosing ovarian granulosa tumor cells and use thereof
10/09/2014WO2014162962A1 Tumor antigen peptide
10/09/2014WO2014162906A1 (sugar chain)-polypeptide complex
10/09/2014WO2014161926A1 Supramolecular aggregates comprising maleimido cores
10/09/2014WO2014161863A1 Dermatological and/or cosmetic peptides for use in skin treatment
10/09/2014WO2014161782A1 Beta-hairpin peptidomimetics
10/09/2014WO2014161781A1 Beta-hairpin peptidomimetics
10/09/2014WO2014161370A1 Protamine peptidomimetic, and pharmaceutically acceptable salts and use thereof
10/09/2014WO2014161118A1 Pentapeptide, polypeptide, cyclopeptide derivative, and compound and medicament and application thereof
10/09/2014WO2014161072A1 Α-boryl isocyanides, boropeptides and boron heterocycles
10/09/2014US20140303343 Cyclosporin a form 2 and method of making same
10/09/2014US20140303084 Pro-Coagulant Compounds and Methods of Use Thereof
10/09/2014US20140303082 Selective gpcr ligands
10/09/2014US20140303075 Chromobacterium Bioactive Compositions and Metabolites
10/09/2014US20140303073 Antisense antiviral compound and method for treating influenza viral infection
10/09/2014US20140303071 Cyclic antimicrobial peptides
10/09/2014US20140303069 Anti-Microbial Peptides and Methods of Use Thereof
10/09/2014US20140302151 Methods and compositions for treating pain
10/09/2014US20140302124 Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
10/09/2014US20140302123 Products useful for the treatment of malignant neoplasms of the human nervous system
10/09/2014US20140302074 Pat-LM1 Epitopes and Methods for Using Same
10/08/2014EP2787079A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY
10/08/2014EP2786766A1 Supramolecular aggregates comprising maleimido cores
10/08/2014EP2785874A1 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
10/07/2014US8853359 Endokinin C/D-derived peptides
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853354 Polyion complex comprising hydrophobized polyamino acid and use of the same
10/07/2014US8853165 Peptide having the ability to regenerate bone tissue and for binding to apatite
10/07/2014US8853164 Oligopeptide improving differentiation of osteoblasts
10/07/2014US8853151 Pro-drug complexes and related methods of use
10/07/2014US8853149 Integrin interaction inhibitors for the treatment of cancer
10/07/2014US8852883 Rapid FRET-based diagnosis of bacterial pathogens
10/07/2014US8852601 Method of stimulating growth and resistance to diseases of aquatic organisms
10/07/2014US8852599 Immunoconjugates, compositions for making them, and methods of making and use
10/07/2014US8852550 Chelator conjugates
10/02/2014WO2014157952A1 Novel syndecan-2 fragment and use thereof
10/02/2014WO2014157704A1 Conjugate vaccine using trimming function of erap1
10/02/2014WO2014157692A1 Wt1-antigen peptide conjugate vaccine
10/02/2014WO2014157485A1 Peptide with anti-aging effect and use thereof
10/02/2014WO2014157229A1 Tace peptide epitope, antihuman tace protein antibody and hybridoma producing antibody
10/02/2014WO2014157169A1 Cleaning agent for washing out silicone contaminant
10/02/2014US20140296482 Method to screen for selective peptides that inhibit the biological activity of calcineurin
10/02/2014US20140296477 Antagonist peptide of the bond between cd47 and a protein belonging to the thrombospondin family
10/02/2014US20140296165 Use of tight junction antagonists to treat inflammatory bowel disease
10/02/2014US20140296164 Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
10/02/2014US20140296163 Methods and Compositions for the Treatment of Gastrointestinal Disorders
10/02/2014US20140296160 Stabilized alpha helical peptides and uses thereof
10/02/2014US20140296156 PEPTIDE BASED INHIBITION OF caPCNA INTERACTION IN CANCER
10/02/2014US20140296153 Oligodendrocyte Differentiation
10/02/2014US20140296144 Process for the preparation of octreotide acetate
10/02/2014US20140296143 Angiotensin-(1-7) As A Chemoprevention Agent
10/02/2014US20140296139 Mitochondrial-derived peptide mots3 regulates metabolism and cell survival
10/02/2014US20140296132 Anti-bacterial Polypeptides and Pathogen Specific Synthetic Antibodies
10/02/2014US20140296130 Novel inhibitors of mammalian tight junction opening
10/02/2014US20140295457 Gene cluster for biosynthesis of griselimycin and methylgriselimycin
10/02/2014US20140294942 Antiviral peptides effective against hepatitis c virus
10/02/2014US20140294902 Novel a4b7 peptide antagonists
10/02/2014US20140294898 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
10/02/2014US20140294894 Transcutaneous delivery of therapeutic agents
10/02/2014US20140294863 Serum albumin binding peptides for tumor targeting
10/02/2014US20140294842 Assays, Methods and Means
10/02/2014US20140294819 Canine/feline cd20 binding epitope and compositions for binding thereto
10/02/2014US20140294763 Peptidomimetic protease inhibitors
10/01/2014EP2784081A1 Development of novel macromolecule transduction domain with improved cell permeability and method for using same
10/01/2014EP2784080A1 Peptide-hinge-free flexible antibody-like molecule
10/01/2014EP2782926A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery
09/2014
09/30/2014US8846889 Peptide biosynthesis and pain therapy
09/30/2014US8846862 Microwave-assisted peptide synthesis
09/30/2014US8846861 Peptide clearing agents
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
09/30/2014US8846610 Methods for preparing purified lipopeptides
09/30/2014US8846608 Human lactoferrin derived peptides and their use
09/30/2014US8846601 Melanocortin receptor-specific peptides
09/30/2014CA2575769C Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof
09/25/2014WO2014153101A2 Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
09/25/2014WO2014152955A1 Apelin fusion proteins and uses thereof
09/25/2014WO2014152751A1 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
09/25/2014WO2014151634A1 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions
09/25/2014WO2014151206A1 Agonists of guanylate cyclase and their uses
09/25/2014WO2014151011A1 Selective inhibitor of angiotensin ii
09/25/2014WO2014150150A1 Enhanced expression of picornavirus proteins
09/25/2014WO2014149001A1 STAPLING eIF4E INTERACTING PEPTIDES
09/25/2014WO2014148620A1 Double-stranded nucleic acid binder, said binder—double-stranded nucleic acid complex, pharmaceutical composition containing said complex, and production method for said complex
09/25/2014WO2014148489A1 Cyclic peptide
09/25/2014WO2014147193A1 New cell-penetrating peptide motifs
09/25/2014WO2014147191A1 Self-cell penetrating fluorescent peptide biosensors to probe and quantify cdk/cyclin kinases
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/25/2014US20140287990 Compositions and methods to concurrently treat and/or prevent multiple diseases with cupredoxins
09/25/2014US20140287989 Compounds Binding to the Bacterial Beta Ring
09/25/2014US20140287986 Template-fixed peptidomimetics as inhibitors of fpr1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 423